Dysregulated cholesterol trafficking through ABCA1 drives neurodegeneration in Parkinson's disease.

Elevated ABCA1 expression in the substantia nigra is linked to cholesterol overload and neurodegeneration in Parkinson's disease mouse models and postmortem brains.

• Why it matters: Cholesterol dysregulation is implicated in Parkinson's disease, but targeting cholesterol synthesis has limited success, highlighting the need to understand cholesterol trafficking mechanisms involved in neurodegeneration.
• What they did: The study used postmortem brain analysis, PD mouse models, and genetic silencing of Abca1 in astrocytes and neurons, along with testing magnesium citrate as an ABCA1 inhibitor, to investigate cholesterol regulation.
• The result: Inhibiting ABCA1 reduces neuronal cholesterol overload, autophagy impairment, alpha-synuclein pathology, and neurodegeneration, suggesting ABCA1 as a promising target for disease-modifying therapies.